Oxytocin Receptor Agonists For Treatment Of Social Anxiety
Funder
National Health and Medical Research Council
Funding Amount
$459,844.00
Summary
At any one time, about 3% of the population suffers from crippling social anxiety disorder, characterized by excessive fear of exposure to situations that involve potential scrutiny by others. Current medications for treating social anxiety are of limited use. This project will develop new drug like molecules that could provide breakthroughs in the effective treatment of social anxiety.
Novel Therapeutics For The Remediation Of Social Deficits In Psychiatric Illness
Funder
National Health and Medical Research Council
Funding Amount
$597,719.00
Summary
Many psychiatric disorders feature a disruption of social behaviour as a central feature of the illness. Examples includes autism, social anxiety disorder, schizophrenia and the addictions. Existing therapies for these disorders rarely improve these core social deficits. We have recently discovered a new molecule (called SOC-1) that stimulates social behaviour in animals. The current project will study how SOC-1 produces these effects and will develop it as a medication for human use.